TY - JOUR
T1 - Combining Prognostic and Predictive Enrichment Strategies to Identify Children with Septic Shock Responsive to Corticosteroids
AU - Wong, Hector R.
AU - Atkinson, Sarah J.
AU - Cvijanovich, Natalie Z.
AU - Anas, Nick
AU - Allen, Geoffrey L.
AU - Thomas, Neal J.
AU - Bigham, Michael T.
AU - Weiss, Scott L.
AU - Fitzgerald, Julie C.
AU - Checchia, Paul A.
AU - Meyer, Keith
AU - Quasney, Michael
AU - Hall, Mark
AU - Gedeit, Rainer
AU - Freishtat, Robert J.
AU - Nowak, Jeffrey
AU - Raj, Shekhar S.
AU - Gertz, Shira
AU - Lindsell, Christopher J.
N1 - Publisher Copyright:
Copyright © 2016 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
PY - 2016/10/1
Y1 - 2016/10/1
N2 - Objectives: Prognostic and predictive enrichment strategies are fundamental tools of precision medicine. Identifying children with septic shock who may benefit from corticosteroids remains a challenge. We combined prognostic and predictive strategies to identify a pediatric septic shock subgroup responsive to corticosteroids. Design: We conducted a secondary analysis of 288 previously published pediatric subjects with septic shock. For prognostic enrichment, each study subject was assigned a baseline mortality probability using the pediatric sepsis biomarker risk model. For predictive enrichment, each study subject was allocated to one of two septic shock endotypes, based on a 100-gene signature reflecting adaptive immunity and glucocorticoid receptor signaling. The primary study endpoint was complicated course, defined as the persistence of two or more organ failures at day 7 of septic shock or 28-day mortality. We used logistic regression to test for an association between corticosteroids and complicated course within endotype. Measurements and Main Results: Among endotype B subjects at intermediate to high pediatric sepsis biomarker risk model-based risk of mortality, corticosteroids were independently associated with more than a 10-fold reduction in the risk of a complicated course (relative risk, 0.09; 95% CI, 0.01-0.54; p = 0.007). Conclusions: A combination of prognostic and predictive strategies based on serum protein and messenger RNA biomarkers can identify a subgroup of children with septic shock who may be more likely to benefit from corticosteroids. Prospective validation of these strategies and the existence of this subgroup are warranted.
AB - Objectives: Prognostic and predictive enrichment strategies are fundamental tools of precision medicine. Identifying children with septic shock who may benefit from corticosteroids remains a challenge. We combined prognostic and predictive strategies to identify a pediatric septic shock subgroup responsive to corticosteroids. Design: We conducted a secondary analysis of 288 previously published pediatric subjects with septic shock. For prognostic enrichment, each study subject was assigned a baseline mortality probability using the pediatric sepsis biomarker risk model. For predictive enrichment, each study subject was allocated to one of two septic shock endotypes, based on a 100-gene signature reflecting adaptive immunity and glucocorticoid receptor signaling. The primary study endpoint was complicated course, defined as the persistence of two or more organ failures at day 7 of septic shock or 28-day mortality. We used logistic regression to test for an association between corticosteroids and complicated course within endotype. Measurements and Main Results: Among endotype B subjects at intermediate to high pediatric sepsis biomarker risk model-based risk of mortality, corticosteroids were independently associated with more than a 10-fold reduction in the risk of a complicated course (relative risk, 0.09; 95% CI, 0.01-0.54; p = 0.007). Conclusions: A combination of prognostic and predictive strategies based on serum protein and messenger RNA biomarkers can identify a subgroup of children with septic shock who may be more likely to benefit from corticosteroids. Prospective validation of these strategies and the existence of this subgroup are warranted.
UR - http://www.scopus.com/inward/record.url?scp=84973375389&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84973375389&partnerID=8YFLogxK
U2 - 10.1097/CCM.0000000000001833
DO - 10.1097/CCM.0000000000001833
M3 - Article
C2 - 27270179
AN - SCOPUS:84973375389
SN - 0090-3493
VL - 44
SP - e1000-e1003
JO - Critical care medicine
JF - Critical care medicine
IS - 10
ER -